{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T22:04:13Z","timestamp":1783548253720,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800065"],"award-info":[{"award-number":["81800065"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20180616"],"award-info":[{"award-number":["BK20180616"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004028","name":"Jiangnan University","doi-asserted-by":"publisher","award":["JUSRP11864"],"award-info":[{"award-number":["JUSRP11864"]}],"id":[{"id":"10.13039\/501100004028","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.intimp.2019.105696","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T10:51:18Z","timestamp":1561027878000},"page":"105696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Baccatin III ameliorates bleomycin-induced pulmonary fibrosis via suppression of TGF-\u03b21 production and TGF-\u03b21-induced fibroblast differentiation"],"prefix":"10.1016","volume":"74","author":[{"given":"Yunjuan","family":"Nie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2019.105696_bb0005","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fmed.2017.00151","article-title":"Diagnosis of idiopathic pulmonary fibrosis \u201cpragmatic challenges in clinical practice\u201d","volume":"4","author":"Tzilas","year":"2017","journal-title":"Front. Med."},{"key":"10.1016\/j.intimp.2019.105696_bb0010","first-page":"1","article-title":"Nintedanib in idiopathic pulmonary fibrosis: practical management recommendations for potential adverse events","author":"Bendstrup","year":"2018","journal-title":"Respiration"},{"issue":"1","key":"10.1016\/j.intimp.2019.105696_bb0015","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12931-018-0876-y","article-title":"Differential effects of nintedanib and pirfenidone on lung alveolar epithelial cell function in ex vivo murine and human lung tissue cultures of pulmonary fibrosis","volume":"19","author":"Lehmann","year":"2018","journal-title":"Respir. Res."},{"key":"10.1016\/j.intimp.2019.105696_bb0020","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3389\/fimmu.2018.00576","article-title":"TNFSF14 (LIGHT) exhibits inflammatory activities in lung fibroblasts complementary to IL-13 and TGF-beta","volume":"9","author":"Silva Antunes","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2019.105696_bb0025","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.intimp.2016.04.016","article-title":"Neotuberostemonine attenuates bleomycin-induced pulmonary fibrosis by suppressing the recruitment and activation of macrophages","volume":"36","author":"Xiang","year":"2016","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2019.105696_bb0030","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.biocel.2010.10.013","article-title":"TGF-beta driven lung fibrosis is macrophage dependent and blocked by serum amyloid P","volume":"43","author":"Murray","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"9","key":"10.1016\/j.intimp.2019.105696_bb0035","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.4049\/jimmunol.0904021","article-title":"Hypoxia-induced mitogenic factor (HIMF\/FIZZ1\/RELMalpha) increases lung inflammation and activates pulmonary microvascular endothelial cells via an IL-4-dependent mechanism","volume":"185","author":"Yamaji-Kegan","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2019.105696_bb0040","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.immunol.21.120601.141142","article-title":"IL-13 effector functions","volume":"21","author":"Wynn","year":"2003","journal-title":"Annu. Rev. Immunol."},{"issue":"46","key":"10.1016\/j.intimp.2019.105696_bb0045","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.1038\/sj.onc.1204629","article-title":"Induction of the IL-13 receptor alpha2-chain by IL-4 and IL-13 in human keratinocytes: involvement of STAT6, ERK and p38 MAPK pathways","volume":"20","author":"David","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2019.105696_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2012.10.553","article-title":"IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes\/macrophages","volume":"54","author":"Bhattacharjee","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2019.105696_bb0055","doi-asserted-by":"crossref","first-page":"9417","DOI":"10.1038\/s41598-017-09639-7","article-title":"A neuropeptide, substance-P, directly induces tissue-repairing M2 like macrophages by activating the PI3K\/Akt\/mTOR pathway even in the presence of IFNgamma","volume":"7","author":"Lim","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.intimp.2019.105696_bb0060","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1165\/rcmb.2016-0259OC","article-title":"NF-kappaB mediates mesenchymal transition, remodeling, and pulmonary fibrosis in response to chronic inflammation by viral RNA patterns","volume":"56","author":"Tian","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"11","key":"10.1016\/j.intimp.2019.105696_bb0065","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1111\/jcmm.12898","article-title":"Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL-1beta\/IL-1R1\/MyD88\/NF-kappaB pathway","volume":"20","author":"Song","year":"2016","journal-title":"J. Cell. Mol. Med."},{"issue":"3","key":"10.1016\/j.intimp.2019.105696_bb0070","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1002\/jcb.27038","article-title":"miR-627\/HMGB1\/NF-kappaB regulatory loop modulates TGF-beta1-induced pulmonary fibrosis","volume":"120","author":"Li","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"11","key":"10.1016\/j.intimp.2019.105696_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206105","article-title":"Transforming growth factor-beta1 in predicting early lung fibroproliferation in patients with acute respiratory distress syndrome","volume":"13","author":"Forel","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2019.105696_bb0080","doi-asserted-by":"crossref","first-page":"7548","DOI":"10.12659\/MSM.912740","article-title":"Oridonin inhibits myofibroblast differentiation and bleomycin-induced pulmonary fibrosis by regulating transforming growth factor beta (TGFbeta)\/Smad pathway","volume":"24","author":"Fu","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.intimp.2019.105696_bb0085","first-page":"279","article-title":"Paclitaxel: new uses for an old drug","volume":"8","author":"Zhang","year":"2014","journal-title":"Drug Des. Devel. Ther."},{"issue":"2","key":"10.1016\/j.intimp.2019.105696_bb0090","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.intimp.2014.06.012","article-title":"Baccatin III, a precursor for the semisynthesis of paclitaxel, inhibits the accumulation and suppressive activity of myeloid-derived suppressor cells in tumor-bearing mice","volume":"21","author":"Lee","year":"2014","journal-title":"Int. Immunopharmacol."},{"issue":"8","key":"10.1016\/j.intimp.2019.105696_bb0095","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.intimp.2011.02.013","article-title":"Baccatin III, a synthetic precursor of taxol, enhances MHC-restricted antigen presentation in dendritic cells","volume":"11","author":"Lee","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2019.105696_bb0100","doi-asserted-by":"crossref","first-page":"7682","DOI":"10.12659\/MSM.909909","article-title":"Attenuation of lipopolysaccharide-induced acute lung injury by cyclosporine-A via suppression of mitochondrial DNA","volume":"24","author":"Xiao","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.intimp.2019.105696_bb0105","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7967868","article-title":"Serotonin exhibits accelerated bleomycin-induced pulmonary fibrosis through TPH1 knockout mouse experiments","volume":"2018","author":"Zhang","year":"2018","journal-title":"Mediat. Inflamm."},{"issue":"7","key":"10.1016\/j.intimp.2019.105696_bb0110","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.12088","article-title":"Automated quantification of renal fibrosis with Sirius Red and polarization contrast microscopy","volume":"2","author":"Street","year":"2014","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.intimp.2019.105696_bb0115","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bcp.2018.05.004","article-title":"Tabersonine attenuates lipopolysaccharide-induced acute lung injury via suppressing TRAF6 ubiquitination","volume":"154","author":"Zhang","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2019.105696_bb0120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-1-4939-8570-8_5","article-title":"Isolation and characterization of mouse fibroblasts","volume":"1809","author":"Edelman","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.intimp.2019.105696_bb0125","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-1-4939-7837-3_6","article-title":"Isolation and identification of interstitial macrophages from the lungs using different digestion enzymes and staining strategies","volume":"1784","author":"Atif","year":"2018","journal-title":"Methods Mol. Biol."},{"issue":"2","key":"10.1016\/j.intimp.2019.105696_bb0130","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1165\/rcmb.2013-0094TR","article-title":"Animal models of fibrotic lung disease","volume":"49","author":"B","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"5","key":"10.1016\/j.intimp.2019.105696_bb0135","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1165\/rcmb.2017-0096ST","article-title":"An official American Thoracic Society workshop report: use of animal models for the preclinical assessment of potential therapies for pulmonary fibrosis","volume":"56","author":"Jenkins","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"7","key":"10.1016\/j.intimp.2019.105696_bb0140","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s12033-018-0090-7","article-title":"Bio-production of Baccatin III, an important precursor of paclitaxel by a cost-effective approach","volume":"60","author":"Lin","year":"2018","journal-title":"Mol. Biotechnol."},{"issue":"2","key":"10.1016\/j.intimp.2019.105696_bb0145","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/01902148.2014.979516","article-title":"The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis","volume":"41","author":"Williamson","year":"2015","journal-title":"Exp. Lung Res."},{"issue":"11","key":"10.1016\/j.intimp.2019.105696_bb0150","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.4049\/jimmunol.1601503","article-title":"AKT2 regulates pulmonary inflammation and fibrosis via modulating macrophage activation","volume":"198","author":"Nie","year":"2017","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2019.105696_bb0155","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1002\/jcp.26112","article-title":"TNF-alpha-induced NF-kappaB activation promotes myofibroblast differentiation of LR-MSCs and exacerbates bleomycin-induced pulmonary fibrosis","volume":"233","author":"Hou","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.intimp.2019.105696_bb0160","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1183\/09031936.03.00014703","article-title":"Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF-beta and IL-10","volume":"22","author":"Bergeron","year":"2003","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.intimp.2019.105696_bb0165","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1165\/rcmb.2006-0121OC","article-title":"Activation of alveolar macrophages via the alternative pathway in herpesvirus-induced lung fibrosis","volume":"35","author":"Mora","year":"2006","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"3","key":"10.1016\/j.intimp.2019.105696_bb0170","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1513\/pats.201203-023AW","article-title":"The impact of TGF-beta on lung fibrosis: from targeting to biomarkers","volume":"9","author":"Fernandez","year":"2012","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"16","key":"10.1016\/j.intimp.2019.105696_bb0175","doi-asserted-by":"crossref","first-page":"E2048","DOI":"10.1073\/pnas.1415111112","article-title":"Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-beta signaling","volume":"112","author":"Oruqaj","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2019.105696_bb0180","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3389\/fphar.2018.00738","article-title":"Casein kinase 1delta\/epsilon inhibitor, PF670462 attenuates the fibrogenic effects of transforming growth factor-beta in pulmonary fibrosis","volume":"9","author":"Keenan","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2019.105696_bb0185","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41374-019-0189-x","article-title":"Surfactant dysfunction and alveolar collapse are linked with fibrotic septal wall remodeling in the TGF-beta1-induced mouse model of pulmonary fibrosis","volume":"99","author":"Beike","year":"2019","journal-title":"Lab. Invest."},{"key":"10.1016\/j.intimp.2019.105696_bb0190","doi-asserted-by":"crossref","first-page":"769830","DOI":"10.1155\/2012\/769830","article-title":"Herbal formula, PM014, attenuates lung inflammation in a murine model of chronic obstructive pulmonary disease","volume":"2012","author":"Lee","year":"2012","journal-title":"Evid. Based Complement. Alternat. Med.: eCAM"},{"issue":"8","key":"10.1016\/j.intimp.2019.105696_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/jcm7080213","article-title":"Molecular targets in Hepatocarcinogenesis and implications for therapy","volume":"7","author":"Wu","year":"2018","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2019.105696_bb0200","article-title":"IL-13 mediates collagen deposition via STAT6 and microRNA-135b: a role for epigenetics","volume":"6","author":"O'Reilly","year":"2016","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.intimp.2019.105696_bb0205","doi-asserted-by":"crossref","first-page":"L1230","DOI":"10.1152\/ajplung.00014.2004","article-title":"Fractalkine\/CX3CL1 production by human airway smooth muscle cells: induction by IFN-gamma and TNF-alpha and regulation by TGF-beta and corticosteroids","volume":"287","author":"Sukkar","year":"2004","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"2","key":"10.1016\/j.intimp.2019.105696_bb0210","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.intimp.2014.07.010","article-title":"Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-kappaB in mice","volume":"22","author":"Gou","year":"2014","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2019.105696_bb0215","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/jcb.27128","article-title":"Sirtuin 6 inhibits myofibroblast differentiation via inactivating transforming growth factor-beta1\/Smad2 and nuclear factor-kappaB signaling pathways in human fetal lung fibroblasts","volume":"120","author":"Zhang","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.intimp.2019.105696_bb0220","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00418-018-1718-1","article-title":"Growth rate and myofibroblast differentiation of desmoid fibroblast-like cells are modulated by TGF-beta signaling","volume":"151","author":"Enzo","year":"2019","journal-title":"Histochem. Cell Biol."},{"issue":"3","key":"10.1016\/j.intimp.2019.105696_bb0225","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1002\/jcp.27073","article-title":"Arsenic trioxide inhibits the differentiation of fibroblasts to myofibroblasts through nuclear factor erythroid 2-like 2 (NFE2L2) protein and the Smad2\/3 pathway","volume":"234","author":"Zhong","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"Pt B","key":"10.1016\/j.intimp.2019.105696_bb0230","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.ijbiomac.2018.07.056","article-title":"Polysaccharides from Dendrobium officinale inhibit bleomycin-induced pulmonary fibrosis via the TGFbeta1-Smad2\/3 axis","volume":"118","author":"Chen","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"issue":"8","key":"10.1016\/j.intimp.2019.105696_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/jcm7080201","article-title":"Idiopathic pulmonary fibrosis (IPF): an overview","volume":"7","author":"Barratt","year":"2018","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.intimp.2019.105696_bb0240","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/MAJ.0b013e31827871dc","article-title":"Pulmonary hypertension and idiopathic pulmonary fibrosis: a dastardly duo","volume":"346","author":"Smith","year":"2013","journal-title":"Am J Med Sci"},{"issue":"146","key":"10.1016\/j.intimp.2019.105696_bb0245","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0057-2017","article-title":"Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis","volume":"26","author":"Lancaster","year":"2017","journal-title":"Eur. Respir. Rev."},{"issue":"145","key":"10.1016\/j.intimp.2019.105696_bb0250","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0071-2017","article-title":"Pharmacotherapy for idiopathic pulmonary fibrosis: current landscape and future potential","volume":"26","author":"Raghu","year":"2017","journal-title":"Eur. Respir. Rev."}],"updated-by":[{"DOI":"10.1016\/j.intimp.2021.108496","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000}}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757691930387X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757691930387X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T19:16:02Z","timestamp":1574450162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757691930387X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":50,"alternative-id":["S156757691930387X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2019.105696","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.intimp.2021.108496","asserted-by":"object"}]},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Baccatin III ameliorates bleomycin-induced pulmonary fibrosis via suppression of TGF-\u03b21 production and TGF-\u03b21-induced fibroblast differentiation","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2019.105696","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105696"}}